{"abnormal behaviour": 6.85, "adverse drug reaction": 9.26, "adverse event": 4.38, "affective disorder": 41.74, "aggression": 33.23, "agitation": 5.09, "anger": 18.15, "anxiety": 3.26, "aura": 57.32, "balance disorder": 3.25, "behaviour disorder": 40.24, "change in seizure presentation": 165.3, "cognitive disorder": 4.94, "depressed mood": 5.53, "depression": 6.69, "diplopia": 3.28, "disturbance in attention": 2.0, "drug ineffective": 2.26, "drug level increased": 16.37, "emotional disorder": 12.48, "epilepsy": 12.39, "feeling abnormal": 2.25, "focal dyscognitive seizures": 44.96, "generalised tonic-clonic seizure": 24.36, "hallucination": 3.23, "insomnia": 2.47, "intentional product misuse": 7.4, "irritability": 13.97, "maternal exposure before pregnancy": 43.59, "maternal exposure during pregnancy": 11.04, "memory impairment": 2.98, "mental disorder": 4.68, "mood altered": 6.1, "mood swings": 10.86, "multiple-drug resistance": 28.85, "off label use": 6.2, "overdose": 14.24, "partial seizures": 43.16, "petit mal epilepsy": 27.74, "prescribed overdose": 8.62, "product availability issue": 49.92, "product dose omission issue": 2.17, "product quality issue": 4.41, "product use issue": 3.86, "psychotic disorder": 16.31, "restlessness": 2.54, "sedation": 7.14, "seizure": 23.15, "sleep disorder": 3.0, "somnolence": 4.59, "status epilepticus": 20.29, "suicidal ideation": 19.18, "therapeutic response unexpected": 4.58, "therapy interrupted": 40.35, "underdose": 7.79, "wrong technique in product usage process": 3.73}